 | • レポートコード：QFJ1-3985 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、細胞＆遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（希少疾患、腫瘍、血液、心臓血管、眼科、神経、その他）、用途別市場規模（製薬＆バイオテクノロジー企業、研究＆学術機関、委託研究機関（CRO）、病院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・細胞＆遺伝子治療の市場動向 ・企業の競争状況、市場シェア ・細胞＆遺伝子治療の種類別市場規模と予測2016-2027（希少疾患、腫瘍、血液、心臓血管、眼科、神経、その他） ・細胞＆遺伝子治療の用途別市場規模と予測2016-2027（製薬＆バイオテクノロジー企業、研究＆学術機関、委託研究機関（CRO）、病院、その他） ・細胞＆遺伝子治療の北米市場規模2016-2027（アメリカ、カナダ） ・細胞＆遺伝子治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・細胞＆遺伝子治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・細胞＆遺伝子治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・細胞＆遺伝子治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen Inc.、bluebird bio, Inc.、Dendreon Pharmaceuticals LLC.、Fibrocell Science, Inc.、Human Stem Cells Institute、Kite Pharma, Inc.、Kolon TissueGene, Inc.、Novartis AG、Orchard Therapeutics plc.、Organogenesis Holdings Inc.、Pfizer, Inc.、RENOVA THERAPEUTICS、Shanghai Sunway Biotech Co., Ltd.,、Sibiono GeneTech Co. Ltd.,、Spark Therapeutics, Inc.、Vericel Corporation、ViroMed Co., Ltd.） ・結論 |
Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting foreign genes into appropriate recipient cells of patients through gene transfer technology, so that the products made by foreign genes can treat certain diseases. Broadly speaking, gene therapy can also include measures and new technologies taken from the DNA level to treat certain diseases. Cell therapy is a brand-new drug development model. In this type of therapy, immune cell therapy has proved to have the most potential. Now researchers have demonstrated its clinical benefits in the treatment of cancer and infectious diseases, and these There are many different characteristics between therapy and traditional therapy, including its ability to expand and contract as needed, and to adjust the therapeutic effect of the body within a few months or years after a single application; due to basic immunology, gene function, gene editing With the continuous application and progress of synthetic biology, the complexity of immune cell therapy has been greatly expanded, which can improve the effectiveness and safety of immune cell therapy, and also increase its potential for treating diseases.
Market Analysis and Insights: Global Cell and Gene Therapy Market
The global Cell and Gene Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell and Gene Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell and Gene Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell and Gene Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell and Gene Therapy market.
Global Cell and Gene Therapy Scope and Market Size
Cell and Gene Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell and Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Rare Diseases
Oncology
Hematology
Cardiovascular
Ophthalmology
Neurology
Other Therapeutic Classes
Segment by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Contract Research Organizations (CROs)
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen Inc.
bluebird bio, Inc.
Dendreon Pharmaceuticals LLC.
Fibrocell Science, Inc.
Human Stem Cells Institute
Kite Pharma, Inc.
Kolon TissueGene, Inc.
Novartis AG
Orchard Therapeutics plc.
Organogenesis Holdings Inc.
Pfizer, Inc.
RENOVA THERAPEUTICS
Shanghai Sunway Biotech Co., Ltd.,
Sibiono GeneTech Co. Ltd.,
Spark Therapeutics, Inc.
Vericel Corporation
ViroMed Co., Ltd.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Rare Diseases
1.2.3 Oncology
1.2.4 Hematology
1.2.5 Cardiovascular
1.2.6 Ophthalmology
1.2.7 Neurology
1.2.8 Other Therapeutic Classes
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research and Academic Institutions
1.3.4 Contract Research Organizations (CROs)
1.3.5 Hospital
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Market Perspective (2016-2027)
2.2 Cell and Gene Therapy Growth Trends by Regions
2.2.1 Cell and Gene Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cell and Gene Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Cell and Gene Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Cell and Gene Therapy Industry Dynamic
2.3.1 Cell and Gene Therapy Market Trends
2.3.2 Cell and Gene Therapy Market Drivers
2.3.3 Cell and Gene Therapy Market Challenges
2.3.4 Cell and Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Players by Revenue (2016-2021)
3.1.2 Global Cell and Gene Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Cell and Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Revenue
3.4 Global Cell and Gene Therapy Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Revenue in 2020
3.5 Cell and Gene Therapy Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Breakdown Data by Type
4.1 Global Cell and Gene Therapy Historic Market Size by Type (2016-2021)
4.2 Global Cell and Gene Therapy Forecasted Market Size by Type (2022-2027)
5 Cell and Gene Therapy Breakdown Data by Application
5.1 Global Cell and Gene Therapy Historic Market Size by Application (2016-2021)
5.2 Global Cell and Gene Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cell and Gene Therapy Market Size (2016-2027)
6.2 North America Cell and Gene Therapy Market Size by Type
6.2.1 North America Cell and Gene Therapy Market Size by Type (2016-2021)
6.2.2 North America Cell and Gene Therapy Market Size by Type (2022-2027)
6.2.3 North America Cell and Gene Therapy Market Size by Type (2016-2027)
6.3 North America Cell and Gene Therapy Market Size by Application
6.3.1 North America Cell and Gene Therapy Market Size by Application (2016-2021)
6.3.2 North America Cell and Gene Therapy Market Size by Application (2022-2027)
6.3.3 North America Cell and Gene Therapy Market Size by Application (2016-2027)
6.4 North America Cell and Gene Therapy Market Size by Country
6.4.1 North America Cell and Gene Therapy Market Size by Country (2016-2021)
6.4.2 North America Cell and Gene Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Market Size (2016-2027)
7.2 Europe Cell and Gene Therapy Market Size by Type
7.2.1 Europe Cell and Gene Therapy Market Size by Type (2016-2021)
7.2.2 Europe Cell and Gene Therapy Market Size by Type (2022-2027)
7.2.3 Europe Cell and Gene Therapy Market Size by Type (2016-2027)
7.3 Europe Cell and Gene Therapy Market Size by Application
7.3.1 Europe Cell and Gene Therapy Market Size by Application (2016-2021)
7.3.2 Europe Cell and Gene Therapy Market Size by Application (2022-2027)
7.3.3 Europe Cell and Gene Therapy Market Size by Application (2016-2027)
7.4 Europe Cell and Gene Therapy Market Size by Country
7.4.1 Europe Cell and Gene Therapy Market Size by Country (2016-2021)
7.4.2 Europe Cell and Gene Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Market Size (2016-2027)
8.2 Asia-Pacific Cell and Gene Therapy Market Size by Type
8.2.1 Asia-Pacific Cell and Gene Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cell and Gene Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cell and Gene Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Cell and Gene Therapy Market Size by Application
8.3.1 Asia-Pacific Cell and Gene Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cell and Gene Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cell and Gene Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Cell and Gene Therapy Market Size by Region
8.4.1 Asia-Pacific Cell and Gene Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cell and Gene Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Market Size (2016-2027)
9.2 Latin America Cell and Gene Therapy Market Size by Type
9.2.1 Latin America Cell and Gene Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Cell and Gene Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Cell and Gene Therapy Market Size by Type (2016-2027)
9.3 Latin America Cell and Gene Therapy Market Size by Application
9.3.1 Latin America Cell and Gene Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Cell and Gene Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Cell and Gene Therapy Market Size by Application (2016-2027)
9.4 Latin America Cell and Gene Therapy Market Size by Country
9.4.1 Latin America Cell and Gene Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Cell and Gene Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Market Size (2016-2027)
10.2 Middle East & Africa Cell and Gene Therapy Market Size by Type
10.2.1 Middle East & Africa Cell and Gene Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cell and Gene Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cell and Gene Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Cell and Gene Therapy Market Size by Application
10.3.1 Middle East & Africa Cell and Gene Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cell and Gene Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cell and Gene Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Cell and Gene Therapy Market Size by Country
10.4.1 Middle East & Africa Cell and Gene Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cell and Gene Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Cell and Gene Therapy Introduction
11.1.4 Amgen Inc. Revenue in Cell and Gene Therapy Business (2016-2021)
11.1.5 Amgen Inc. Recent Development
11.2 bluebird bio, Inc.
11.2.1 bluebird bio, Inc. Company Details
11.2.2 bluebird bio, Inc. Business Overview
11.2.3 bluebird bio, Inc. Cell and Gene Therapy Introduction
11.2.4 bluebird bio, Inc. Revenue in Cell and Gene Therapy Business (2016-2021)
11.2.5 bluebird bio, Inc. Recent Development
11.3 Dendreon Pharmaceuticals LLC.
11.3.1 Dendreon Pharmaceuticals LLC. Company Details
11.3.2 Dendreon Pharmaceuticals LLC. Business Overview
11.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Introduction
11.3.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Business (2016-2021)
11.3.5 Dendreon Pharmaceuticals LLC. Recent Development
11.4 Fibrocell Science, Inc.
11.4.1 Fibrocell Science, Inc. Company Details
11.4.2 Fibrocell Science, Inc. Business Overview
11.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Introduction
11.4.4 Fibrocell Science, Inc. Revenue in Cell and Gene Therapy Business (2016-2021)
11.4.5 Fibrocell Science, Inc. Recent Development
11.5 Human Stem Cells Institute
11.5.1 Human Stem Cells Institute Company Details
11.5.2 Human Stem Cells Institute Business Overview
11.5.3 Human Stem Cells Institute Cell and Gene Therapy Introduction
11.5.4 Human Stem Cells Institute Revenue in Cell and Gene Therapy Business (2016-2021)
11.5.5 Human Stem Cells Institute Recent Development
11.6 Kite Pharma, Inc.
11.6.1 Kite Pharma, Inc. Company Details
11.6.2 Kite Pharma, Inc. Business Overview
11.6.3 Kite Pharma, Inc. Cell and Gene Therapy Introduction
11.6.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Business (2016-2021)
11.6.5 Kite Pharma, Inc. Recent Development
11.7 Kolon TissueGene, Inc.
11.7.1 Kolon TissueGene, Inc. Company Details
11.7.2 Kolon TissueGene, Inc. Business Overview
11.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Introduction
11.7.4 Kolon TissueGene, Inc. Revenue in Cell and Gene Therapy Business (2016-2021)
11.7.5 Kolon TissueGene, Inc. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Cell and Gene Therapy Introduction
11.8.4 Novartis AG Revenue in Cell and Gene Therapy Business (2016-2021)
11.8.5 Novartis AG Recent Development
11.9 Orchard Therapeutics plc.
11.9.1 Orchard Therapeutics plc. Company Details
11.9.2 Orchard Therapeutics plc. Business Overview
11.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Introduction
11.9.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Business (2016-2021)
11.9.5 Orchard Therapeutics plc. Recent Development
11.10 Organogenesis Holdings Inc.
11.10.1 Organogenesis Holdings Inc. Company Details
11.10.2 Organogenesis Holdings Inc. Business Overview
11.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Introduction
11.10.4 Organogenesis Holdings Inc. Revenue in Cell and Gene Therapy Business (2016-2021)
11.10.5 Organogenesis Holdings Inc. Recent Development
11.11 Pfizer, Inc.
11.11.1 Pfizer, Inc. Company Details
11.11.2 Pfizer, Inc. Business Overview
11.11.3 Pfizer, Inc. Cell and Gene Therapy Introduction
11.11.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Business (2016-2021)
11.11.5 Pfizer, Inc. Recent Development
11.12 RENOVA THERAPEUTICS
11.12.1 RENOVA THERAPEUTICS Company Details
11.12.2 RENOVA THERAPEUTICS Business Overview
11.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Introduction
11.12.4 RENOVA THERAPEUTICS Revenue in Cell and Gene Therapy Business (2016-2021)
11.12.5 RENOVA THERAPEUTICS Recent Development
11.13 Shanghai Sunway Biotech Co., Ltd.,
11.13.1 Shanghai Sunway Biotech Co., Ltd., Company Details
11.13.2 Shanghai Sunway Biotech Co., Ltd., Business Overview
11.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Introduction
11.13.4 Shanghai Sunway Biotech Co., Ltd., Revenue in Cell and Gene Therapy Business (2016-2021)
11.13.5 Shanghai Sunway Biotech Co., Ltd., Recent Development
11.14 Sibiono GeneTech Co. Ltd.,
11.14.1 Sibiono GeneTech Co. Ltd., Company Details
11.14.2 Sibiono GeneTech Co. Ltd., Business Overview
11.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Introduction
11.14.4 Sibiono GeneTech Co. Ltd., Revenue in Cell and Gene Therapy Business (2016-2021)
11.14.5 Sibiono GeneTech Co. Ltd., Recent Development
11.15 Spark Therapeutics, Inc.
11.15.1 Spark Therapeutics, Inc. Company Details
11.15.2 Spark Therapeutics, Inc. Business Overview
11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Introduction
11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Business (2016-2021)
11.15.5 Spark Therapeutics, Inc. Recent Development
11.16 Vericel Corporation
11.16.1 Vericel Corporation Company Details
11.16.2 Vericel Corporation Business Overview
11.16.3 Vericel Corporation Cell and Gene Therapy Introduction
11.16.4 Vericel Corporation Revenue in Cell and Gene Therapy Business (2016-2021)
11.16.5 Vericel Corporation Recent Development
11.17 ViroMed Co., Ltd.
11.17.1 ViroMed Co., Ltd. Company Details
11.17.2 ViroMed Co., Ltd. Business Overview
11.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Introduction
11.17.4 ViroMed Co., Ltd. Revenue in Cell and Gene Therapy Business (2016-2021)
11.17.5 ViroMed Co., Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cell and Gene Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Rare Diseases
Table 3. Key Players of Oncology
Table 4. Key Players of Hematology
Table 5. Key Players of Cardiovascular
Table 6. Key Players of Ophthalmology
Table 7. Key Players of Neurology
Table 8. Key Players of Other Therapeutic Classes
Table 9. Global Cell and Gene Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Cell and Gene Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Cell and Gene Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Cell and Gene Therapy Market Share by Regions (2016-2021)
Table 13. Global Cell and Gene Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Cell and Gene Therapy Market Share by Regions (2022-2027)
Table 15. Cell and Gene Therapy Market Trends
Table 16. Cell and Gene Therapy Market Drivers
Table 17. Cell and Gene Therapy Market Challenges
Table 18. Cell and Gene Therapy Market Restraints
Table 19. Global Cell and Gene Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Cell and Gene Therapy Market Share by Players (2016-2021)
Table 21. Global Top Cell and Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell and Gene Therapy as of 2020)
Table 22. Ranking of Global Top Cell and Gene Therapy Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Cell and Gene Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cell and Gene Therapy Product Solution and Service
Table 26. Date of Enter into Cell and Gene Therapy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cell and Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Cell and Gene Therapy Revenue Market Share by Type (2016-2021)
Table 30. Global Cell and Gene Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Cell and Gene Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Cell and Gene Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Cell and Gene Therapy Revenue Market Share by Application (2016-2021)
Table 34. Global Cell and Gene Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Cell and Gene Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Cell and Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Cell and Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Cell and Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Cell and Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Cell and Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Cell and Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Cell and Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Cell and Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Cell and Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Cell and Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Cell and Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Cell and Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cell and Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cell and Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cell and Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Cell and Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Cell and Gene Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Cell and Gene Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Cell and Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Cell and Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Cell and Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Cell and Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Cell and Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Cell and Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cell and Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cell and Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cell and Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Cell and Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Cell and Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Cell and Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 66. Amgen Inc. Company Details
Table 67. Amgen Inc. Business Overview
Table 68. Amgen Inc. Cell and Gene Therapy Product
Table 69. Amgen Inc. Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 70. Amgen Inc. Recent Development
Table 71. bluebird bio, Inc. Company Details
Table 72. bluebird bio, Inc. Business Overview
Table 73. bluebird bio, Inc. Cell and Gene Therapy Product
Table 74. bluebird bio, Inc. Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 75. bluebird bio, Inc. Recent Development
Table 76. Dendreon Pharmaceuticals LLC. Company Details
Table 77. Dendreon Pharmaceuticals LLC. Business Overview
Table 78. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product
Table 79. Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 80. Dendreon Pharmaceuticals LLC. Recent Development
Table 81. Fibrocell Science, Inc. Company Details
Table 82. Fibrocell Science, Inc. Business Overview
Table 83. Fibrocell Science, Inc. Cell and Gene Therapy Product
Table 84. Fibrocell Science, Inc. Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 85. Fibrocell Science, Inc. Recent Development
Table 86. Human Stem Cells Institute Company Details
Table 87. Human Stem Cells Institute Business Overview
Table 88. Human Stem Cells Institute Cell and Gene Therapy Product
Table 89. Human Stem Cells Institute Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 90. Human Stem Cells Institute Recent Development
Table 91. Kite Pharma, Inc. Company Details
Table 92. Kite Pharma, Inc. Business Overview
Table 93. Kite Pharma, Inc. Cell and Gene Therapy Product
Table 94. Kite Pharma, Inc. Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 95. Kite Pharma, Inc. Recent Development
Table 96. Kolon TissueGene, Inc. Company Details
Table 97. Kolon TissueGene, Inc. Business Overview
Table 98. Kolon TissueGene, Inc. Cell and Gene Therapy Product
Table 99. Kolon TissueGene, Inc. Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 100. Kolon TissueGene, Inc. Recent Development
Table 101. Novartis AG Company Details
Table 102. Novartis AG Business Overview
Table 103. Novartis AG Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 104. Novartis AG Recent Development
Table 105. Orchard Therapeutics plc. Company Details
Table 106. Orchard Therapeutics plc. Business Overview
Table 107. Orchard Therapeutics plc. Cell and Gene Therapy Product
Table 108. Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 109. Orchard Therapeutics plc. Recent Development
Table 110. Organogenesis Holdings Inc. Company Details
Table 111. Organogenesis Holdings Inc. Business Overview
Table 112. Organogenesis Holdings Inc. Cell and Gene Therapy Product
Table 113. Organogenesis Holdings Inc. Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 114. Organogenesis Holdings Inc. Recent Development
Table 115. Pfizer, Inc. Company Details
Table 116. Pfizer, Inc. Business Overview
Table 117. Pfizer, Inc. Cell and Gene Therapy Product
Table 118. Pfizer, Inc. Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 119. Pfizer, Inc. Recent Development
Table 120. RENOVA THERAPEUTICS Company Details
Table 121. RENOVA THERAPEUTICS Business Overview
Table 122. RENOVA THERAPEUTICS Cell and Gene Therapy Product
Table 123. RENOVA THERAPEUTICS Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 124. RENOVA THERAPEUTICS Recent Development
Table 125. Shanghai Sunway Biotech Co., Ltd., Company Details
Table 126. Shanghai Sunway Biotech Co., Ltd., Business Overview
Table 127. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product
Table 128. Shanghai Sunway Biotech Co., Ltd., Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 129. Shanghai Sunway Biotech Co., Ltd., Recent Development
Table 130. Sibiono GeneTech Co. Ltd., Company Details
Table 131. Sibiono GeneTech Co. Ltd., Business Overview
Table 132. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product
Table 133. Sibiono GeneTech Co. Ltd., Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 134. Sibiono GeneTech Co. Ltd., Recent Development
Table 135. Spark Therapeutics, Inc. Company Details
Table 136. Spark Therapeutics, Inc. Business Overview
Table 137. Spark Therapeutics, Inc. Cell and Gene Therapy Product
Table 138. Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 139. Spark Therapeutics, Inc. Recent Development
Table 140. Vericel Corporation Company Details
Table 141. Vericel Corporation Business Overview
Table 142. Vericel Corporation Cell and Gene Therapy Product
Table 143. Vericel Corporation Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 144. Vericel Corporation Recent Development
Table 145. ViroMed Co., Ltd. Company Details
Table 146. ViroMed Co., Ltd. Business Overview
Table 147. ViroMed Co., Ltd. Cell and Gene Therapy Product
Table 148. ViroMed Co., Ltd. Revenue in Cell and Gene Therapy Business (2016-2021) & (US$ Million)
Table 149. ViroMed Co., Ltd. Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell and Gene Therapy Market Share by Type: 2020 VS 2027
Figure 2. Rare Diseases Features
Figure 3. Oncology Features
Figure 4. Hematology Features
Figure 5. Cardiovascular Features
Figure 6. Ophthalmology Features
Figure 7. Neurology Features
Figure 8. Other Therapeutic Classes Features
Figure 9. Global Cell and Gene Therapy Market Share by Application: 2020 VS 2027
Figure 10. Pharmaceutical and Biotechnology Companies Case Studies
Figure 11. Research and Academic Institutions Case Studies
Figure 12. Contract Research Organizations (CROs) Case Studies
Figure 13. Hospital Case Studies
Figure 14. Others Case Studies
Figure 15. Cell and Gene Therapy Report Years Considered
Figure 16. Global Cell and Gene Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Cell and Gene Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Cell and Gene Therapy Market Share by Regions: 2020 VS 2027
Figure 19. Global Cell and Gene Therapy Market Share by Regions (2022-2027)
Figure 20. Global Cell and Gene Therapy Market Share by Players in 2020
Figure 21. Global Top Cell and Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell and Gene Therapy as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Revenue in 2020
Figure 23. Global Cell and Gene Therapy Revenue Market Share by Type (2016-2021)
Figure 24. Global Cell and Gene Therapy Revenue Market Share by Type (2022-2027)
Figure 25. North America Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Cell and Gene Therapy Market Share by Type (2016-2027)
Figure 27. North America Cell and Gene Therapy Market Share by Application (2016-2027)
Figure 28. North America Cell and Gene Therapy Market Share by Country (2016-2027)
Figure 29. United States Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Cell and Gene Therapy Market Share by Type (2016-2027)
Figure 33. Europe Cell and Gene Therapy Market Share by Application (2016-2027)
Figure 34. Europe Cell and Gene Therapy Market Share by Country (2016-2027)
Figure 35. Germany Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Cell and Gene Therapy Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Cell and Gene Therapy Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Cell and Gene Therapy Market Share by Region (2016-2027)
Figure 45. China Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Cell and Gene Therapy Market Share by Type (2016-2027)
Figure 53. Latin America Cell and Gene Therapy Market Share by Application (2016-2027)
Figure 54. Latin America Cell and Gene Therapy Market Share by Country (2016-2027)
Figure 55. Mexico Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Cell and Gene Therapy Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Cell and Gene Therapy Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Cell and Gene Therapy Market Share by Country (2016-2027)
Figure 61. Turkey Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Cell and Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Amgen Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 65. bluebird bio, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 66. Dendreon Pharmaceuticals LLC. Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 67. Fibrocell Science, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 68. Human Stem Cells Institute Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 69. Kite Pharma, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 70. Kolon TissueGene, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 71. Novartis AG Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 72. Orchard Therapeutics plc. Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 73. Organogenesis Holdings Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 74. Pfizer, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 75. RENOVA THERAPEUTICS Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 76. Shanghai Sunway Biotech Co., Ltd., Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 77. Sibiono GeneTech Co. Ltd., Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 78. Spark Therapeutics, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 79. Vericel Corporation Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 80. ViroMed Co., Ltd. Revenue Growth Rate in Cell and Gene Therapy Business (2016-2021)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
世界の細胞・遺伝子治療用ツール＆試薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cell and Gene Therapy Tools and Reagents Market The global Cell and Gene Therapy Tools and Reagents market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…- 世界の遺伝子治療医薬品（GTMP）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gene Therapy Medicinal Products (GTMP) Market The global Gene Therapy Medicinal Products (GTMP) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…
- 世界の自己細胞療法市場規模・現状・予測（2021年-2027年） Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is t…
- 世界の遺伝子検出用個別化癌治療市場規模・現状・予測（2021年-2027年） A method to provide patients with individualized treatment of cancer tumors Market Analysis and Insights: Global Gene Detection for Individualized Cancer Therapy Market The global Gene Detection for Individualized Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX m…
- 世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allogeneic Stem Cell Therapy Market The global Allogeneic Stem Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…